Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
A preliminary report on the "SNBTS Evaluation of the Ortho HCV Antibody ELISA Test System" looked at transfusion recipients, and found that 1 in 33 multi-transfused patients screened positive (3%). 92 of 146 people with haemophilia from the West of Scotland whose samples were tested were shown to be repeatedly reactive for anti-HCV (63%).
Published on:
09 September, 2024
Dr Metters reported to the meeting that France, Belgium and Luxembourg had all commenced mandatory screening, while Italy had introduced optional screening.
Published on:
09 September, 2024
Arrangements for implementing anti-HCV screening were discussed in detail by the Advisory Committee on Transfusion Transmitted Diseases.
Published on:
09 September, 2024
Dr Contreras wrote that, "We are extremely busy with our Business Plans and contracts as well as dealing with the extra workload incurred as a result of the Gulf War and we cannot give anti-HCV screening the priority required by the Department of Health."
Published on:
09 September, 2024
A letter from S McDougall to Dr Gunson noted that the commencement of routine anti-HCV testing at the Cambridge RTC was unlikely to start before 1 October 1991.
Published on:
09 September, 2024
A letter from Dr Fereydoun Ala to Dr Gunson noted that routine testing for HCV in the West Midlands RTC could begin by April 1991.
Published on:
09 September, 2024
A letter from Professor Cash to Dr Gunson noted that a May/June date might be anticipated to commence anti-HCV testing in Scotland.
Published on:
09 September, 2024
A letter from Dr Martlew to Dr Gunson noted that they would prefer to delay the implementation of anti-HCV testing at the Liverpool RTC to 1 August 1991.
Published on:
09 September, 2024
A letter from Dr Fraser to Dr Gunson stated that 1 July 1991 would be the most appropriate date to start anti-HCV testing at the Bristol RTC.
Published on:
09 September, 2024
A letter from Jean Harrison to Dr Gunson stated that the earliest the Brentwood RTC could start anti-HCV testing would be 15 April 1991, but the preferred start date would be 1 May 1991 or 1 June 1991.
Published on:
09 September, 2024
A letter from Dr Gunson to Dr Contreras stated that the Department of Health had not asked for any priority to be given to anti-HCV screening and that he would advise Dr Contreras of the financial arrangements to be made as soon as he could.
Published on:
09 September, 2024
A memo from Tony Martin to Dr Gunson noted that 1 June 1991 would be an achievable start date to commence anti-HCV screening for the South Thames Blood Transfusion Service.
Published on:
09 September, 2024
A letter from Dr Douglas Lee to Dr Gunson stated that the earliest date to which he could commit the North West to routine anti-HCV testing would be 1 June 1991.
Published on:
09 September, 2024
A letter from Dr Lloyd to Dr Gunson stated that the Northern Region Blood Transfusion Service would be able to start anti-HCV testing from approximately 1 April 1991.
Published on:
09 September, 2024
The Advisory Committee on Transfusion Transmitted Diseases was informed that the proposed starting date of 1991 for anti-HCV screening was difficult because it was considered essential to evaluate the new generation Ortho and Abbott tests prior to the commence of routine screening.
Published on:
09 September, 2024
Dr Lloyd wrote to Dr Gunson outlining his reasons for commencing anti-HCV testing in the Northern Region earlier than other RTCs in July 1991. He stated the decision to start testing was based on an imperfect test, but a test that was nonetheless available and which detected a group of people who appeared to be positive for the antibody. The comparative study of the Abbott and Ortho kits would not have influenced his decision as to whether or not to start testing.
Published on:
09 September, 2024
Dr Lloyd wrote to all RTC directors informing them that by 1 July all units of blood for transfusion in the Northern Region would be negative for Hepatitis C antibody. He stated that to not test now, when they had the ability to do so, would be indefensible under Product Liability legislation.
Published on:
09 September, 2024
Dr Lloyd received a letter of objection from Dr Mitchell in respect of awaiting an informed judgment on testing and Dr Lloyd's decision to commence anti-HCV screening in the Northern Region earlier than the rest of the RTCs.
Published on:
09 September, 2024
Professor Cash defined Dr Lloyd's unilateral action to commence anti-HCV screening earlier than other RTCs as both "disgraceful and mischievous".
Published on:
09 September, 2024
Dr Boulton wrote to Dr Lloyd stating that Dr Lloyd's decision to start HCV-testing earlier than the other RTCs was "breaking ranks" and "not conducive to the image of a co-ordinated Service".
Published on:
18 October, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2400
Page
2401
Page
2402
Page
2403
Current page
2404
Page
2405
Page
2406
Page
2407
Page
2408
…
Next page
Next
Last page
Last